Cardiovascular Diseases and the Role of Stents in Treatment Cardiovascular diseases have remained one of the leading causes of mortality globally for decades.
Lorecivivint is superior to placebo for improving pain, function, and structure at 12 months and beyond in patients with knee osteoarthritis, according to data presented at ACR Convergence 2024.